Articles tagged with Breast Cancer
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
A new study by the Mayo Clinic found that the Gail model, a widely used statistical tool for predicting breast cancer risk, was not reliable for women with atypical hyperplasia. The study tested the model in 331 women with atypia and found it predicted significantly fewer invasive breast cancers than were actually observed.
A study found that daily folic acid and B vitamin supplements had no impact on cancer risk in high-risk women. The results suggest a lack of benefit for total invasive cancer and breast cancer, with age modifying the effect.
HER2-positive breast cancer can be more aggressive due to the suppression of its own regulator gene Lig-1. Researchers found that when Lig-1 levels are low, cancer cells grow faster.
Researchers at Georgetown University Medical Center have found a novel way in which breast cancer cells become resistant to tamoxifen, a world's largest-selling breast cancer prevention and treatment drug. The study suggests that the gamma estrogen-related receptor subtype may be stimulating cancer growth.
Clemson University researchers have received a $180,000 grant to develop new imaging agents that combine light and MRI technology for early detection of breast cancers. The technology uses fluorescent carbon nanomaterials, dubbed 'carbon dots', with magnetic elements to enhance contrast and spatial resolution.
A study of over 32,000 American women found that vigorous physical activity significantly lowers the risk of breast cancer. While non-vigorous activities did not offer protection, researchers suggest mechanisms like reduced inflammation and immune function may contribute to this benefit.
Breast cancer survivors with lymphedema often don't treat their symptoms, with 29-65% of patients taking no action. Patients who do manage their symptoms use a mix of recommended techniques, pharmaceutical treatments, and lay therapies. The study aims to address the gap in treatment and develop effective management techniques.
The occurrence of hot flushes and joint symptoms during endocrine treatment for breast cancer can indicate a reduced chance of cancer recurrence, suggesting treatment success. Women with hormone-receptor-positive tumours who reported these symptoms had lower recurrence rates compared to those without symptoms.
Research found skewed X inactivation in women with BRCA1 gene mutations, associated with a later onset of breast or ovarian cancer. The Impact of Cancer scale was also refined and validated, providing a tool to measure long-term psychosocial impact on cancer survivors.
New report finds lung cancer media coverage is on the rise, but with a significant decrease in positive coverage and an overemphasis on smoking as a risk factor. Despite this, breast cancer coverage remains more favorable, often featuring personal stories of survivors.
New research suggests that statins may significantly reduce the occurrence of venous thromboembolism in patients with solid organ tumors. The study found that patients receiving statins were less likely to develop blood clots, with a significant reduction in incidence compared to those who did not use statins.
Scientists have developed a new imaging agent using bevacizumab, which surpasses existing methods in detecting tumors. The compound successfully targets cancer cells and provides clearer images of tumors, enabling earlier stages of detection and fewer false positives.
A new study published in Radiology found that 3-D power Doppler ultrasound can accurately distinguish between malignant and benign breast masses. The technique detects higher flow velocities in malignant tumor-feeding vessels, making it a potentially useful tool for breast cancer diagnosis.
Researchers found that chronic inflammation can nurture skin cancer by exploiting the IDO enzyme's suppressive immune response. This is analogous to chronic sun exposure and skin cancer, where UV radiation causes malignant skin cells to appear while also causing skin inflammation.
A recent study published in Journal of Clinical Sleep Medicine found that respiratory rhythms and cortisol levels can predict chronic insomnia in women with metastatic breast cancer. Breathing exercises such as yoga and meditation may help alleviate sleep disruptions, which are common among cancer patients.
The USPSTF recommends primary care interventions to promote breastfeeding, with coordinated interventions increasing initiation, duration, and exclusivity. Breastfeeding has substantial health benefits to babies and their mothers, including reduced infections, allergic skin rashes, and type 2 diabetes.
Researchers found that women with metastatic breast cancer experience sleep disturbances due to autonomic nervous system dysregulation. Insomnia symptoms are associated with lower baseline respiratory sinus arrhythmia and increased stress levels.
Researchers used a new technique to study gene expression in stored liver tissue samples, identifying a tell-tale genetic profile that indicates likelihood of recurrence. The analysis revealed a characteristic gene expression signature in 186 genes that reliably correlated with high tumor recurrence rates.
A new approach to genetic testing for cancers in Australia could effectively halve deaths caused by an inherited form of bowel cancer. By testing tumors of young people with cancer, researchers can identify inherited genetic faults and prevent further cases.
The Notch pathway plays a crucial role in regulating breast stem cell fate, controlling both stem cell number and the production of luminal cells. Errant activation of Notch leads to uncontrolled growth of luminal precursors, resulting in breast tumour formation.
Four recipients of the ASPS Patients of Courage award have undergone extensive reconstructive plastic surgeries to restore their appearance. Erin Williams, Rachel Cooney, Missy Fish, and Sgt. Robert Bartlett use their experiences to help others struggling with life's obstacles.
A study published in the Journal of the National Cancer Institute found that tamoxifen treatment may advance detection of ER-negative breast cancer in high-risk women, shortening the time to diagnosis by approximately 1 year. The drug does not alter the risk of ER-positive disease.
A large review of 38 studies found regular NSAID use associated with reduced breast cancer risk. Aspirin and Advil showed significant protective effects, with a 13-21% relative risk reduction.
Researchers propose a nested case-control study design called PRoBE to evaluate biomarker classification accuracy, minimizing bias. Regular NSAID use is associated with a 12% relative risk reduction in breast cancer risk, according to a meta-analysis of 38 studies involving 2,788,715 women.
Researchers discovered that tamoxifen can reduce the median time to diagnosis of ER-negative breast cancer by a year, improving detection rates through mammography. The study suggests an unexpected link between tamoxifen use and earlier disease identification in high-risk patients.
Researchers at University of Missouri are studying the interactions between black cohosh and tamoxifen in a unique rat model to understand its safety and effectiveness. The goal is to provide reliable information on how women can use herbal supplements to enhance their breast cancer treatment and improve quality of life.
The new guidelines provide a tiered system of resource allocation to implement early detection, diagnosis, and treatment programs. The initiative aims to improve breast health outcomes in low- and middle-income countries, where cancer mortality rates are highest.
A study of 215 women who underwent BRCA testing found that personal beliefs about inconclusive results are a strong predictor of psychological adjustment. Women with higher levels of worry and distress were more likely to struggle with the uncertainty of their test results.
A study found that birth weight is associated with an increased risk of breast cancer later in life, particularly among women living in developed countries. The analysis of over 600,000 women revealed a 7% increase in risk for every 0.5 kg increment in birth weight.
Researchers developed a new MRI technique that can detect tiny breast cancers, including ductal carcinoma in situ (DCIS), in mice. The method has shown promising results in detecting small tumors less than 300 microns in diameter and distended milk ducts with cancer.
A new study published in PLOS Medicine found that birth size is a significant marker of susceptibility to breast cancer later in life. The research analyzed data from over 600,000 women and discovered that a 0.5 kg increase in birth weight was associated with a 7% higher risk of breast cancer. Birth length and head circumference were a...
A study analyzing English cancer patients found that cervical and lung cancer rates are higher among poor people, while breast and melanoma rates are higher in wealthier groups. Smoking is strongly associated with socioeconomic status and contributes to the higher incidence of lung cancer in deprived groups.
A retrospective study found that women with 3 or fewer involved lymph nodes have a low relapse rate after undergoing pre-operative chemotherapy and mastectomy. Patients with zero involved lymph nodes had a zero percent recurrence rate.
A new predictive measurement, called a PEPI score, can help determine the treatment of breast cancer patients. A low PEPI score indicates little risk of relapse and allows patients to safely avoid chemotherapy after surgery. Women with high PEPI scores are at high risk of having their cancer return and require aggressive therapy.
Research finds activation of Src signaling pathway contributes to treatment resistance in some patients with triple-negative breast cancer. Inhibiting this pathway holds promise as a way to overcome resistance and improve patient outcomes.
The breast cancer incidence in China is expected to increase due to lifestyle changes and adoption of Western lifestyles. Researchers predict a total of 2.5 million cases by 2012, with modifications to lifestyle and reproductive risk factors potentially preventing 270,000 cases.
Researchers developed a preoperative endocrine prognostic index (PEPI) to predict relapse risk in women with stage 2 or 3 estrogen receptor-positive breast cancer. The model incorporates tumor characteristics and is statistically significant in predicting relapse-free survival.
A recent observational study published in the Journal of the National Cancer Institute suggests that hormone therapy may be safe for postmenopausal women with BRCA mutations. The study found a 42% relative reduction in breast cancer risk among women who used hormone therapy, although further research is needed to confirm these findings.
A study found that genistein, a soy-based dietary supplement, can negate the effectiveness of aromatase inhibitors used to treat post-menopausal breast cancer. The researchers observed a dose-dependent reduction in treatment efficacy, leading to tumor growth.
A new report shows that racial disparities in cancer incidence are declining in Missouri, with the gap narrowing between African Americans and whites. However, racial disparities in cancer death rates remain higher for African Americans, despite efforts to reduce them.
A new type of accelerated partial breast irradiation (APBI) called balloon brachytherapy is as effective in keeping breast cancer from coming back as standard external beam radiation. This shorter treatment option makes radiation therapy more convenient for patients, potentially increasing the rate of breast conservation.
A randomized study found that accelerated hypofractionated whole breast irradiation is as effective as standard five-week treatment in reducing local recurrence and side effects. The new therapy reduces the radiation time to three weeks, resulting in a cost savings of two-thirds compared to traditional treatment.
A randomized clinical trial shows acupuncture reduces hot flashes and vasomotor symptoms in breast cancer patients, providing additional benefits like increased energy and well-being. The treatment has no side effects compared to commonly used drugs.
A study by Fox Chase Cancer Center found that breast cancer survivors reported a high level of overall quality of life several years after treatment, with some improvements over time. The survey tool used measured health outcomes using the EQ-5D instrument and compared results to a general US adult population.
A new study suggests that breast MRI scans can help determine if women scheduled to undergo surgery will later need radiation therapy. The research found that tumors' physiological information shown on MRI scans correlated with surgically based findings of cancer having spread to lymph nodes.
Researchers at the University of Toronto have discovered that two protein cousins, related to the p53 family, play a critical role in cancer development. The findings challenge traditional thinking and suggest a new branch of scientific inquiry into cancer development.
A new advance in cellular imaging allows scientists to track the movement of live cells in the area around tumors, providing insights into how certain immune cells help or hinder tumor growth. This study sheds light on potential drug targets and mechanisms to enhance the body's natural immune response to cancer.
Studies in mice reveal that women who have children young have fewer mammary stem cells, which could contribute to lower breast cancer risk. Researchers plan to investigate further to determine the mechanism behind this protective effect and explore potential treatments.
Researchers found that adding four cycles of Taxotere to a sequential regimen of epirubicin and cyclophosphamide, methotrexate and fluorouracil reduces recurrence and death rates in patients with node-positive early stage breast cancer. This advantage comes at an increased toxicity level.
Researchers found that computer models underpredicted BRCA mutation frequency in Asian-American women by 50% compared to Caucasian counterparts. This suggests that more women of Asian descent may be at increased risk of hereditary breast and ovarian cancers than previously believed.
Regular breast cancer screening programs in developed countries show promise for reducing mortality in India. A new study estimates that annual or biennial clinical breast exams can lower mortality rates by 8.2% and gain life years at a cost-effectiveness of $1,135 per life-year gained.
A study adjusting for a known bias in familial melanoma risk estimates reveals an increased relative risk of 3.18, with higher risks for young-onset cases. In contrast, the risks for colorectal, lung, breast, and prostate cancer remain relatively stable.
Researchers found that anti-angiogenic drugs block chemotherapy-induced blood vessel formation, thereby hindering tumor regrowth. This mechanism may explain why some chemotherapy combinations enhance treatment efficacy.
Australian scientists identified four groupings of genes related to breast cancer cell behavior and their impact on tamoxifen treatment. This discovery could help clinicians predict which women will respond well to anti-oestrogen therapies.
A new study suggests that routine use of MRI scans in women with newly-diagnosed breast cancer may lead to delays in treatment and an increase in mastectomies. The study found that younger women were more likely to receive MRIs, but failed to improve surgical outcomes.
A new treatment strategy involving sorafenib could 're-sensitize' tumors, enabling anti-hormonal drugs like aromatase inhibitors to be effective again. Preliminary analysis shows a clinical benefit response in 26 percent of patients taking both sorafenib and anastrozole.
The study identifies frequently mutated genes, including ERBB2 and NF1, which were previously underestimated in their role in glioblastoma. The analysis also provides a wide view of how cell pathways are altered during the initiation and growth of glioblastoma, offering insights into strategies to diagnose and treat the disease.
A nationwide study found that black women are less likely than white women to receive standard radiation therapy after a lumpectomy, with significant regional variations. The disparity affects over 37,000 patients and highlights the need for further research into underlying reasons and potential barriers to care.
Researchers at M.D. Anderson Cancer Center discovered that 50% of HER2-positive breast cancer patients showed no signs of disease after surgery treated with Herceptin. However, some patients developed tumors that converted from HER2 positive to negative status, suggesting potential resistance to the therapy.
A substudy of the IBIS II trial found no significant differences in cognitive assessments between postmenopausal women receiving anastrozole and placebo, but noted more endocrine symptoms such as hot flushes in the anastrozole group.